Haemate (Human Coagulation Factor VIII + Von Willebrand Factor)

Name:

Title/Position:

Affiliation / Organization:

Years of experience in hematology/coagulation research and practice:

How familiar are you with Haemate, the combination of human coagulation factor 8 and von Willebrand factor?

• Very familiar
• Somewhat familiar
• Not familiar at all

What do you consider as the key advantages of combining factor 8 and von Willebrand factor in a single product?

Are there any concerns or potential challenges you foresee in the use of Haemate? If so, please elaborate.

In which patient populations do you foresee Haemate being particularly beneficial?

What specific clinical scenarios or situations do you believe Haemate could address effectively?

What, in your opinion, sets Haemate as described above apart from existing treatments for bleeding disorders?